Clinical trial
Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Lithium in Bipolar I Disorder
NCT00422331 is registered in ClinicalTrials.gov with JDS Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Lithium in Bipolar I Disorder
- Lead sponsor
- JDS Pharmaceuticals
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- January 31, 2007
- Completion date
- December 31, 2007
- Enrollment
- 206 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.